• Twitter()
  • Facebook()
  • Print this Story
  • Email this Story
Text Size AAA

Current Funding Opportunity from the Department of Defense

Modified: September 7, 2015

DoD Breast Cancer Breakthrough Award Levels 1 and 2 (W81XWH-15-BCRP-BREAKTHROUGH2-FL12)

The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are:

Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.

Research Scope: Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Two different funding levels, based on the scope of the research, are available under this Program Announcement/Funding Opportunity. An additional funding level, Funding Level 3, is available under a different Program Announcement (W81XWH-15-BCRP-BREAKTHROUGH2_FL3). It is the responsibility of the Principal Investigator (PI) to select the funding level that is most appropriate for the research proposed. The funding level should be selected based on the scope of the research project, rather than the amount of the budget.

The following are general descriptions, although not all-inclusive, of the scope of research projects that would be appropriate to propose under each funding level:

  • Funding Level 1: Innovative, high-risk/high-reward research that is in the earliest stages of idea development. Research with potential to yield new avenues of investigation. Proof of concept. No preliminary data required.

  • Funding Level 2: Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation. Demonstration of efficacy in in vivo models, as applicable.

DEADLINE(S):
Pre-Application Deadline (Required): November 18th at 4:00 p.m. (CST)
Application Submission DeadlineDecember 2nd at 10:59 p.m. CST

For more information, please visit the DoD Grant webpage or view the complete RFP here

COLLABORATION OPPORTUNITIES:
The Office of Research Development offers assistance in identifying and facilitating collaborations, putting together interdisciplinary teams, programmatic and administrative development of large, cross-school proposals, and leveraging institutional resources for outreach and education. Contact Fruma Yehiely, Director of ORD, for more information.

Announcements, Funding Connection